Vireo Growth Inc.
VREO
CNSX
Weiss Ratings | VREO - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | E | |||
Rating Factors | VREO - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Very Weak | |||
Solvency Index | Good | |||
Total Return Index | Fair | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | VREO - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.08 | |||
Price History | VREO - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -12.86% | |||
30-Day Total Return | -3.17% | |||
60-Day Total Return | -22.78% | |||
90-Day Total Return | 23.23% | |||
Year to Date Total Return | -24.69% | |||
1-Year Total Return | 19.61% | |||
2-Year Total Return | 320.69% | |||
3-Year Total Return | -76.63% | |||
5-Year Total Return | 40.23% | |||
52-Week High % Change | -40.40% | |||
52-Week Low % Change | 81.54% | |||
Price | VREO - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $0.99 | |||
52-Week Low Price | $0.33 | |||
52-Week Low Price (Date) | Dec 16, 2024 | |||
52-Week High Price (Date) | Dec 18, 2024 | |||
Valuation | VREO - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 151.35M | |||
Enterprise Value | 149.83M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.14 | |||
Earnings Per Share Growth | -25.13% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 1.38 | |||
Price/Book (Q) | 3.89 | |||
Enterprise Value/Revenue (TTM) | 1.51 | |||
Price | $0.61 | |||
Enterprise Value/EBITDA (TTM) | 7.85 | |||
Enterprise Value/EBIT | 8.29 | |||
Market Cap Category | Micro Cap | |||
Dividends and Shares | VREO - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 232.65M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | VREO - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 612 999 1606 | |||
Address | 207 South 9th Street Minneapolis, MN 55402 | |||
Website | www.vireogrowth.com | |||
Country | United States | |||
Year Founded | 2004 | |||
Profitability | VREO - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 18.17% | |||
Profit Margin | -28.18% | |||
Management Effectiveness | VREO - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 4.89% | |||
Return on Equity | -- | |||
Income Statement | VREO - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 99.38M | |||
Total Revenue (TTM) | 99.38M | |||
Revenue Per Share | $0.43 | |||
Gross Profit (TTM) | 50.77M | |||
EBITDA (TTM) | 19.08M | |||
EBIT (TTM) | 18.07M | |||
Net Income (TTM) | -28.01M | |||
Net Income Avl. to Common (TTM) | -28.01M | |||
Total Revenue Growth (Q YOY) | 3.52% | |||
Earnings Growth (Q YOY) | -242.61% | |||
EPS Diluted (TTM) | -0.14 | |||
EPS Diluted Growth (Q YOY) | -110.94% | |||
Balance Sheet | VREO - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 91.61M | |||
Cash Per Share (Q) | $0.39 | |||
Total Current Assets (Q) | 230.37M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 55.56M | |||
Current Ratio (Q) | 1.701 | |||
Book Value Per Share (Q) | $0.15 | |||
Total Assets (Q) | 278.86M | |||
Total Current Liabilities (Q) | 135.47M | |||
Total Debt (Q) | 90.09M | |||
Total Liabilities (Q) | 223.30M | |||
Total Common Equity (Q) | 55.56M | |||
Cash Flow | VREO - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -8.13M | |||
Cash from Financing (TTM) | 94.01M | |||
Net Change in Cash (TTM) | 75.64M | |||
Levered Free Cash Flow (TTM) | -5.60M | |||
Cash from Operations (TTM) | -10.23M | |||